Jersey Shore University Medical Center   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Neptune Township NJ United States (1904)

Organization Overview

First Clinical Trial
1997
NCT00003118
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (2)

cisplatin (platinol) (1 trial)

fluorouracil (efudex) (1 trial)

Drugs in Phase 2 Trials (3)

bezlotoxumab (zinplava) (1 trial)

sivifene (1 trial)

sodium chloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cervical Intraepithelial Neoplasia (Phase 2)

Clostridium Infections (Phase 2)

Esophageal Neoplasms (Phase 3)

Neoplasms (Phase 2)

Squamous Intraepithelial Lesions of the Cervix (Phase 2)

Uterine Cervical Dysplasia (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 5